Research Associate: Analytics, Cell & Gene Therapies

About the role

We are immediately hiring two driven Research Associates to support a growing portfolio of advanced cell and gene therapies (CGT), including CAR-T, iPSC, AAV, LVV and synthetic DNA products. In this hands-on, lab-based role, you will develop, qualify, and execute methods for CGT product release and characterization while collaborating with analytical, process, engineering, manufacturing, and compliance teams. This is an opportunity to learn from mentors while managing analytical tasks in a fast-paced environment to test product safety, identity, potency, purity, and quality, including compendial applications.

The role requires working on-site at Landmark Bio/Artis BioSolutions in Watertown, MA, with flexible schedules to support technical operations.

Responsibilities

• Develop, optimize, and transfer PCR methods (qPCR, dPCR, ddPCR) for molecular testing.
• Support automated cell counters, cell-based cytotoxicity assays, flow cytometry, and ELISA-based testing.
• Perform analysis of extracellular vesicles and particles using Nanoparticle Tracking, Light Scattering, and Nano Flow Cytometry.
• Run and troubleshoot UHPLC methods (Reverse Phase, Size Exclusion) for purity and residual analysis.
• Maintain precise electronic lab notebooks and draft GMP technical protocols or reports.
• Calibrate lab instrumentation, troubleshoot performance errors, and handle routine equipment upkeep.
• Follow all environmental health and safety standards while meeting regulatory guidelines.

Requirements

• Bachelor's or Master's degree in Biology, Biotechnology, Molecular Biology, or a related field.
• Minimum of 1+ years of work experience, preferably in a cGMP biotechnology manufacturing setting or equivalent higher degree academic research.
• Experience with cell/gene therapy, analytical problem-solving, and strong oral and written communication.
• Hands-on experience in one or more relevant lab techniques (PCR, UHPLC, Cell-based or Molecular).
• Familiarity with cGMP and cell and gene therapy regulatory frameworks.
• Valid, unrestricted work authorization in the U.S. and availability to start immediately.